Spyglass Discover
Payments companies reported to CMS as associated with Spyglass Discover. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spyglass Discover, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spyglass Discover
These are the largest totals companies reported as associated with Spyglass Discover. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ahsun Riaz | Chicago, IL | Vascular & Interventional Radiology | $40,434.06 |
| Filippo Filicori | New York, NY | $30,731.71 | |
| Diya Alaedeen | Miami, FL | Surgery | $26,160.78 |
| Omar Bellorin-Marin | Teaneck, NJ | Surgery | $25,913.87 |
| Horacio Asbun | Miami, FL | Surgical Oncology | $24,220.94 |
| Ezra Teitelbaum | Milwaukee, WI | Surgery | $22,976.92 |
| Eric Pauli | Hershey, PA | Surgery | $21,369.55 |
| Edward Jones | Denver, CO | Surgery | $20,874.58 |
| Michael Ujiki | Evanston, IL | Surgery | $20,219.62 |
| Bradley Reames | Omaha, NE | Surgical Oncology | $19,782.75 |
Prescribed Spyglass Discover?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.